Medicines Evaluation Unit (MEU)
Meet MEU at the UK Pavilion (Hall B, Stand 2348).
Medicines Evaluation Unit (MEU) Ltd is one of the UK’s leading CROs, a facility where commitment to excellence is paramount. MEU possess extensive pharmaceutical, scientific and clinical expertise, allied with fast volunteer recruitment, within a state-of-the-art hospital-based research facility.
MEU offer products and services to enable better, safer and more efficient study designs, particularly in complex patient groups. MEU’s bespoke, phenotyped database and trial management system (ICARUS), assists rapid study recruitment ensuring we meet our clients’ timelines. ICARUS possesses over 32,000 active volunteer profiles and enables MEU to assess protocol inclusion criteria, and accurately provide real-time feasibility.
MEU has a team of experienced Principal Investigators led by the world-renowned respiratory KOL Professor Dave Singh, MEU Medical Director. To accelerate drug discovery, MEU have a host of human lung tissue models for target identification and validation studies. The techniques used include cell culture, immunoassays, immunohistochemistry, PCR and flow cytometry.
Micropore Technologies
Meet Micropore Technologies at the UK Pavilion (Hall B, Stand 2348).
Micropore Technologies offers savings in development time, increased yields and simplified operation for those engaged in development and manufacture of parenterals, particularly nano-and micro- sized particles for application in LNPs, PNPs, Polymer microspheres (eg PLGA, PLA), Hydrogels, and many others. We also support our clients with their GMP qualification requirements.
Headquartered in the UK, Micropore has offices in USA and India and has agents in Japan and Australia.
